Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
By Pat Rizzuto
Aug. 31 — The Environmental Protection Agency is scheduled to release Sept. 1 a draft assessment of a fuel oxygenate called ethyl tertiary butyl ether, according to a prepublication Federal Register notice.
Ethyl tertiary butyl ether is used as a fuel additive for gasoline to increase octane rating and has been used to meet air pollution reduction goals under the Clean Air Act, according to information from the EPA. The use of oxygenates such as ETBE in reformulated gasoline in the U.S. was effectively eliminated in 2006, but use and production has continued to increase gasoline’s octane rating, the EPA said.
The assessment, conducted under EPA’s Integrated Risk Information System (IRIS), will examine the human health hazards of ETBE and the doses at which those hazards could manifest. Final IRIS assessments, or “toxicological reviews,” are used throughout the agency, U.S. states and regulators in other parts of the world as part of the information they use to assess the risks a chemical poses at a particular site or when used in particular ways. The resulting risk assessments contribute to decisions on whether an industrial activity, hazardous waste site, or other situation needs to be regulated.
Lyondell Chemical Co. and one other company, which claimed its name to be confidential business information, were the two U.S. manufacturers of ETBE in 2011, the most recent year for which U.S. production data is available from the EPA. The agency withheld ETBE’s national production volume information to protect proprietary information.
European companies that have registered ETBE include BP p.l.c., Exxon Mobil Corp. SABIC Petrochemicals and Shell. The oxygenate is registered as having an annual European production volume of 1 million to 10 million metric tons.
The EPA’s IRIS program has not issued a final assessment of ETBE previously, although the agency published a draft assessment in 2009. That draft assessment proposed to classify ETBE as having “suggestive evidence of carcinogenic potential.” It also proposed a reference concentration (RfC) of 0.006 milligrams per cubic meter of air. RfCs are the agency’s estimate of a continuous does that people could inhale over their lifetime without expectation of harm.
The ETBE assessment, however, was among four IRIS chemical evaluations the agency placed on hold after the U.S. National Toxicology Program and an Italian research organization called the Ramazzini Institute reached divergent opinions on cancer data the institute had generated.
In a 2013 presentation, the IRIS program said it was again reviewing ETBE. It was examining kidney, liver, reproductive, developmental and carcinogenic effects, among other potential health problems.
Following that meeting, the Petroleum Industry Technology and Research Institute Inc. of Japan sent the EPA a letter arguing that ETBE did not meet the criteria for an IRIS assessment.
“Current uses of ETBE in the United States are virtually non-existent. Manufacture of ETBE in the U.S. is predominately for export only,” the Japanese trade association wrote.
Questions about the effects ethyl tertiary butyl ether may have on the liver are among the issues the EPA also will discuss at an Oct. 26 public science meeting.
To contact the reporter on this story: Pat Rizzuto in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Larry Pearl at email@example.com
A prepublication copy of EPA’s Federal Register notice announcing the ETBE assessment is available at http://src.bna.com/ib3.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)